Use of systemic glucocorticoids and the risk of colorectal cancer

Alimentary Pharmacology and Therapeutics

Volumn 37, Issue 1, 2013, Pages 146-152

  Ostenfeld, E B ^a   Erichsen, R ^a   Thorlacius Ussing, O ^a   Riis, A H ^a   Sorensen H T ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; PREDNISOLONE;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RISK; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; DISEASE REGISTRY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METASTASIS; POPULATION BASED CASE CONTROL STUDY; POPULATION RISK; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SYSTEMIC THERAPY; TREATMENT DURATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DENMARK; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 84870593177     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12115     Document Type: Article

References (30)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM,. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
2. Danish Medicines Agency. Sales of Medicinal Products Within the Different ATC Groups in the Primary Healthcare Sector. Medicinal Product Statistics 2006-2010. Denmark Copenhagen: Danish Medicines Agency, 2011; 80.
3. Sorensen HT, Mellemkjaer L, Nielsen GL, Baron JA, Olsen JH, Karagas MR,. Skin cancers and non-hodgkin lymphoma among users of systemic glucocorticoids: a population-based cohort study. J Natl Cancer Inst 2004; 96: 709-11.
4. Karagas MR, Cushing GL Jr, Greenberg ER, Mott LA, Spencer SK, Nierenberg DW,. Non-melanoma skin cancers and glucocorticoid therapy. Br J Cancer 2001; 85: 683-6.
5. Jensen AO, Thomsen HF, Engebjerg MC, et al,. Use of oral glucocorticoids and risk of skin cancer and non-Hodgkin's lymphoma: a population-based case-control study. Br J Cancer 2009; 100: 200-5.
6. Dietrich K, Schned A, Fortuny J, et al,. Glucocorticoid therapy and risk of bladder cancer. Br J Cancer 2009; 101: 1316-20.
7. Severi G, Baglietto L, Muller DC, et al,. Asthma, asthma medications, and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2010; 19: 2318-24.
8. Schimmer BP, Parker KL,. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In:, Brunton LL, Lazo JS, Parker KL, eds. Goodman and Gilman's the Pharmacological Basis of Therapeutics. New York: McGraw-Hill Medical Publishing Division, 2006; 1587-612.
9. Dunn GP, Koebel CM, Schreiber RD,. Interferons, immunity and cancer immunoediting. Nat Rev Immunol 2006; 6: 836-48.
10. Fulop T, Larbi A, Kotb R, de Angelis F, Pawelec G,. Aging, immunity, and cancer. Discov Med 2011; 11: 537-50.
11. Schacke H, Docke WD, Asadullah K,. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 2002; 96: 23-43.
12. Siddiqui AA,. Metabolic syndrome and its association with colorectal cancer: a review. Am J Med Sci 2011; 341: 227-31.
13. Lin JH, Morikawa T, Chan AT, et al,. Postmenopausal hormone therapy is associated with a reduced risk of colorectal cancer lacking CDKN1A expression. Cancer Res 2012; 72: 3020-8.
14. Subramanian V, Logan RF,. Chemoprevention of colorectal cancer in inflammatory bowel disease. Best Pract Res Clin Gastroenterol 2011; 25: 593-606.
15. Statistics Denmark. StatBank Denmark. 2012. Available at: http://www.statistikbanken.dk/statbank5a/SelectVarVal/Define.asp?Maintable= FOLK1&PLanguage=1. Accessed September 20, 2012.
16. Storm HH, Michelsen EV, Clemmensen IH, Pihl J,. The Danish Cancer Registry-history, content, quality and use. Dan Med Bull 1997; 44: 535-9.
17. Gjerstorff ML,. The Danish Cancer Registry. Scand J Public Health 2011; 39 (Suppl.): 42-5.
18. Sobin LH,. TNM: evolution and relation to other prognostic factors. Semin Surg Oncol 2003; 21: 3-7.
19. Pedersen CB,. The Danish Civil Registration System. Scand J Public Health 2011; 39 (Suppl.): 22-5.
20. Ehrenstein V, Antonsen S, Pedersen L,. Existing data sources for clinical epidemiology: Aarhus University Prescription Database. Clin Epidemiol 2010; 2: 273-9.
21. Jacobs JWG, Bijlsma JWJ,. Glucocorticoid Therapy. In:, Firestein GS, Budd RC, Harris ED, McInnes IB, Sergent JS, eds. Kelly's Textbook of Rheumatology. 8th ed. St. Louis, MO: W.B. Saunders Company, 2008; 863.
22. Sorensen GV, Cronin-Fenton DP, Sorensen HT, Ulrichsen SP, Pedersen L, Lash TL,. Use of glucocorticoids and risk of breast cancer: a Danish population-based case-control study. Breast Cancer Res 2012; 14: R21.
23. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH,. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263-8.
24. Hosmer DW, Lemeshow S, The Multinomal Logistic Regression Model. Applied Logistic Regression. 2nd ed. Hoboken NJ: John Wiley and Sons, Inc., 2000; 260.
25. Nielsen GL, Sorensen HT, Mellemkjoer L, et al,. Risk of hospitalization resulting from upper gastrointestinal bleeding among patients taking corticosteroids: a register-based cohort study. Am J Med 2001; 111: 541-5.
26. Parimon T, Chien JW, Bryson CL, McDonell MB, Udris EM, Au DH,. Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175: 712-9.
27. Sorensen HT, Lash TL, Rothman KJ,. Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies. Hepatology 2006; 44: 1075-82.
28. Johannesdottir SA, Maegbaek ML, Hansen JG, Lash TL, Pedersen L, Ehrenstein V,. Correspondence between general practitioner reported medication use and timing of prescription dispensation. Clin Epidemiol 2012; 4: 13-8.
29. Mellemkjaer L, Blot WJ, Sorensen HT, et al,. Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark. Br J Clin Pharmacol 2002; 53: 173-81.
30. Rothwell PM, Wilson M, Elwin CE, et al,. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 2010; 376: 1741-50.